Iatrogenic hemodilution: a possible cause for avoidable blood transfusions?

A restrictive approach to blood transfusions is recommended by most current guidelines [1, 2]. Others suggest that in some patients a more liberal transfusion strategy may be beneficial [3]. However, the extensive discussions regarding the appropriate transfusion threshold have not adequately addressed the potential impact of iatrogenic hemodilution on the hemoglobin (Hb) level during dynamic clinical…

Read More

Big Pharma is ‘TERRIFIED’ of Vitamin D

Dr. Pierre Kory: Big Pharma is ‘TERRIFIED’ of Vitamin DWhy?Because “It threatens the DISEASE MODEL.”A new meta-analysis out of Italy, published in the journal, Nutrients, has unearthed some shocking data about Vitamin D.Looking at data from 16 different studies and 1.26 million individuals, the meta-analysis revealed:• Vitamin D showed about a 60% effectiveness against the…

Read More

Cancer as a Mitochondrial Metabolic Disease – Dr. Thomas Seyfried

On September 21, 2024, Professor Thomas Seyfried presented at a BSI Medical Society event in Boston. His talk focuses on cancer as a mitochondrial metabolic disease rather than a genetic one. Seyfried challenges the mainstream somatic mutation theory, which suggests that genetic mutations drive cancer. Instead, he argues that cancer arises from chronic mitochondrial damage…

Read More